The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress
Open accessAbstract
Axonal degeneration is a prominent feature of many neurological disorders that are associated with mitochondrial dysfunction, including Parkinson's disease, motor neuron disease, and inherited peripheral neuropathies. Studies of the Wld s mutant mouse, which undergoes delayed Wallerian degeneration in response to axonal injury, suggest that axonal degeneration is an active process. Wld s mice also have slower axonal degeneration and disease progression in numerous models of neurodegenerative disease. The Wld s mutation results in the production of a chimeric protein that contains the full-length coding sequence of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1), which alone is sufficient for axonal protection in vitro . To test the effects of increased Nmnat expression on axonal degeneration induced by mitochondrial dysfunction, we examined dorsal root ganglion (DRG) neurons treated with rotenone. Rotenone induced profound axonal degeneration in DRG neurons; however, this degeneration was delayed by expression of Nmnat. Nmnat-mediated protection resulted in decreased axonal accumulation and sensitivity to reactive oxygen species (ROS) but did not affect the change in the rate of rotenone-induced loss in neuronal ATP. Nmnat also prevented axonal degeneration caused by exposure to exogenous oxidants and reduced the level of axonal ROS after treatment with vincristine, further supporting the idea that Nmnat promotes axonal protection by mitigating the effects of ROS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mammals, over-expressing NMNATs significantly delays Wallerian degeneration of peripheral nerves (28)(29)(30)(31)(32)(33).”
From CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy (2012) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, NMNAT over-expression can prevent axonal damage resulting from exogenous application of oxidants (28).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D., Richfield, E., Buckley, B., & Mirochnitchenko, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500417200 · Cited by 84 · cited 1×
“Protection of oxidant-mediated axonal damage by Nmnat suggested that it might act via increasing neuronal expression of antioxidant proteins, including superoxide dismutase, glutathione peroxidase, and/or catalase (Thiruchelvam et al., 2005; Fernandez-Gomez et al., 2006; Jung et al., 2007).”
BackgroundRetractedMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 4×
“Mitochondrial dysfunction caused by mutations or toxic agents has been implicated in many neurodegenerative diseases, including those associated with axonal degeneration (Lin and Beal, 2006).”
BackgroundInfluentialChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 2×
“, DJ-1 and PINK-1) (Martin, 2006) and ingestion of 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP), an inhibitor of mitochondrial complex I (Langston et al., 1983; Betarbet et al., 2000).”
BackgroundChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,777 · cited 8×
“…Parkinson’s disease (PD), which can be associated with mutations in mitochondria-associated proteins (e.g., DJ-1 and PINK-1) (Martin, 2006) and ingestion of 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP), an inhibitor of mitochondrial complex I (Langston et al., 1983; Betarbet et al., 2000).”
BackgroundMethodResultInfluentialDopamine (3-hydroxytyramine) and brain function.
Hornykiewicz, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,389 · cited 2×
“…chronic rotenone model of PD, which more closely mimics the degenerative progression observed in PD patients, because this model only works in rats (Hornykiewicz, 1966; Betarbet et al., 2000; Richter et al., 2007); however, our results suggest that increasing Nmnat expression in this model may…”
ResultMechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T., Betarbet, R. S., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno‐Yagi, A., & Greenamyre, J. T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,102 · cited 6×
“The suppression of ROS accumulation by Nmnat proteins is reminiscent of that observed in cells treated with antioxidants, whose utility in preventing axonal degeneration secondary to mitochondrial inhibition has been suggested by others (Sherer et al., 2003, 2007; Testa et al., 2005).”
BackgroundMethodInfluentialIncreased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · cited 13×
“…axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam et al., 2003; Araki et al., 2004; Gillingwater et al., 2004; Mi et al., 2005; Sasaki et al., 2006; Zhai et al., 2006).”
BackgroundMethodResultInfluentialSelf-citationAxon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · cited 2×
“These changes are followed by calpain activation and eventual axonal protein degradation (Coleman, 2005).”
BackgroundKeeney, P. M., Xie, J., Capaldi, R., & Bennett, J. P. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 765 · cited 3×
“For example, complex I inhibition and oxidative damage to mitochondrial proteins have been observed in brains of PD patients, changes that can be replicated by treatment of isolated mitochondria with rotenone (Keeney et al., 2006).”
BackgroundThe risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
Gorell, J., Johnson, C. C., Rybicki, B., Peterson, E., & Richardson, R. (1998) · Neurology · doi:10.1212/wnl.50.5.1346 · Cited by 694 · cited 1×
“…of PD (Sherer et al., 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
BackgroundAbramov, A. Y., Scorziello, A., & Duchen, M. R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4468-06.2007 · Cited by 686 · cited 2×
“…of ROS, other sources of ROS production include membrane-bound NADPH-oxidase, a source of oxidative products induced in neurons by signaling intermediates, and xanthine oxidase, which produces ROS in neurons in response to hypoxia and glucose deprivation (Ibi et al., 2006; Abramov et al., 2007).”
BackgroundAxonal Self-Destruction and Neurodegeneration
Raff, M., Whitmore, A., & Finn, J. (2002) · Science · doi:10.1126/science.1068613 · Cited by 670 · cited 2×
“Studies of the Wld mutant mouse, which exhibits slow axonal Wallerian degeneration in response to nerve injury, have led to the conclusion that axonal degeneration, like apoptosis, is an active process (Lunn et al., 1989; Raff et al., 2002).”
BackgroundStys, P., Waxman, S., & Ransom, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00430.1992 · Cited by 662 · cited 1×
“One model of axonal degeneration derives from studies of anoxic injury to axons, which leads to mitochondrial failure, decreased levels of ATP, reduced Na /K ATPase activity, and increased axonal Na and Ca 2 (Stys et al., 1992).”
BackgroundAbsence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., & Gordon, S. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00771.x · Cited by 646 · cited 2×
“Studies of the Wld mutant mouse, which exhibits slow axonal Wallerian degeneration in response to nerve injury, have led to the conclusion that axonal degeneration, like apoptosis, is an active process (Lunn et al., 1989; Raff et al., 2002).”
BackgroundWallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
Mack, T. G. A., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., et al. (2001) · Nature Neuroscience · doi:10.1038/nn770 · Cited by 611 · cited 1×
“Interestingly, the production and usage of NAD and its metabolites can play important roles in antioxidant responses (Mack et al., 2001).”
BackgroundSherer, T., Betarbet, R. S., Stout, A. K., Lund, S. A., Baptista, M. J., Panov, A. V., Cookson, M., & Greenamyre, J. T. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 586 · cited 3×
“It is generally accepted that environmental factors play an important role in the pathogenesis of PD (Sherer et al., 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al.,…”
BackgroundMethodThe Drosophila Cell Corpse Engulfment Receptor Draper Mediates Glial Clearance of Severed Axons
MacDonald, J. M., Beach, M. G., Porpiglia, E., Sheehan, A. E., Watts, R. J., & Freeman, M. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.04.028 · Cited by 523 · cited 1×
“Many studies in both rodents and Drosophila have confirmed these results (Hoopfer et al., 2006; Macdonald et al., 2006; Zhai et al., 2006), whereas other investigators have suggested the Ube4b fragment may modulate the Nmnat protective effect (Wang et al., 2005; Conforti et al., 2007).”
ResultBerger, F., Lau, C., Dahlmann, M., & Ziegler, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508660200 · Cited by 508 · cited 2×
“adenine dinucleotide (NAD ) (Araki et al., 2004; Berger et al., 2005), although recent studies in Drosophila neurodegeneration have suggested that additional Nmnat activities may also be important for synaptic protection (Zhai et al.”
BackgroundEnvironmental risk factors and Parkinson's disease: a metaanalysis.
Priyadarshi, A., Khuder, S., Schaub, E., & Priyadarshi, S. (2001) · Environmental Research · doi:10.1006/enrs.2001.4264 · Cited by 481 · cited 1×
“…of PD (Sherer et al., 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
BackgroundPesticide exposure and risk for Parkinson's disease
Ascherio, A., Chen, H., Weisskopf, M. G., O’Reilly, É. J., McCullough, M. L., Calle, E. E., Schwarzschild, M. A., & Thun, M. J. (2006) · Annals of Neurology · doi:10.1002/ana.20904 · Cited by 481 · cited 2×
“, 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
BackgroundParkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K., Love, E., & Lee, R. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 471 · cited 2×
“, 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
BackgroundPesticides and Parkinson’s Disease—Is There a Link?
Brown, T. P., Rumsby, P. C., Capleton, A. C., Rushton, L., & Levy, L. S. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8095 · Cited by 451 · cited 2×
“, 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
BackgroundBaloh, R. H., Schmidt, R. E., Pestronk, A., & Milbrandt, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4798-06.2007 · Cited by 450 · cited 1×
“It results in a host of cellular abnormalities, including decreased ATP synthesis, disrupted mitochondrial fusion and transport, and the increased generation of reactive oxygen species (ROS) (Lin and Beal, 2006; Baloh et al., 2007).”
BackgroundSelf-citationA local mechanism mediates NAD-dependent protection of axon degeneration
Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M. W., & He, Z. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504028 · Cited by 352 · cited 4×
“Many studies in both rodents and Drosophila have confirmed these results (Hoopfer et al., 2006; Macdonald et al., 2006; Zhai et al., 2006), whereas other investigators have suggested the Ube4b fragment may modulate the Nmnat protective effect (Wang et al., 2005; Conforti et al., 2007).”
BackgroundResultInfluentialSherer, T., Richardson, J. R., Testa, C. M., Seo, B. B., Panov, A. V., Yagi, T., Matsuno‐Yagi, A., Miller, G. W., & Greenamyre, J. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04333.x · Cited by 348 · cited 3×
“The suppression of ROS accumulation by Nmnat proteins is reminiscent of that observed in cells treated with antioxidants, whose utility in preventing axonal degeneration secondary to mitochondrial inhibition has been suggested by others (Sherer et al., 2003, 2007; Testa et al., 2005).”
BackgroundInfluentialAlexandre, J., Batteux, F., Nicco, C., Chéreau, C., Laurent, A., Guillevin, L., Weill, B. J., & Goldwasser, F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21685 · Cited by 316 · cited 2×
“This would imply, as suggested by others, that ROS-stimulated processes could be a point of convergence for multiple pathways that culminate in axonal degeneration (Arundine et al., 2004; Alexandre et al., 2006; Holtz et al., 2006).”
BackgroundTesta, C. M., Sherer, T., & Greenamyre, J. T. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.007 · Cited by 296 · cited 4×
“The suppression of ROS accumulation by Nmnat proteins is reminiscent of that observed in cells treated with antioxidants, whose utility in preventing axonal degeneration secondary to mitochondrial inhibition has been suggested by others (Sherer et al., 2003, 2007; Testa et al., 2005).”
BackgroundResultInfluentialMitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures.
Nicholls, D. (2004) · Current molecular medicine · doi:10.2174/1566524043479239 · Cited by 276
White matter injury mechanisms.
Stys, P. (2004) · Current molecular medicine · doi:10.2174/1566524043479220 · Cited by 270 · cited 3×
“TTX treatment should serve to increase neuro- nal ATP levels, because it inhibits the influx of sodium and negates the need to expend ATP for maintaining axonal membrane potential via the Na /K ATPase (Stys, 2004).”
BackgroundSasaki, Y., Araki, T., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2320-06.2006 · Cited by 269 · cited 10×
“…axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam et al., 2003; Araki et al., 2004; Gillingwater et al., 2004; Mi et al., 2005; Sasaki et al., 2006; Zhai et al., 2006).”
BackgroundMethodResultInfluentialSelf-citationHoopfer, E. D., McLaughlin, T., Watts, R. J., Schuldiner, O., O’Leary, D. D. M., & Luo, L. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.013 · Cited by 258 · cited 1×
“Many studies in both rodents and Drosophila have confirmed these results (Hoopfer et al., 2006; Macdonald et al., 2006; Zhai et al., 2006), whereas other investigators have suggested the Ube4b fragment may modulate the Nmnat protective effect (Wang et al., 2005; Conforti et al., 2007).”
ResultConforti, L., Tarlton, A., Mack, T. G. A., Mi, W., Buckmaster, E. A., Wagner, D., Perry, V. H., & Coleman, M. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11377 · Cited by 251 · cited 2×
“and the full-length nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) protein (Conforti et al., 2000).”
BackgroundInfluentialEnvironment, Mitochondria, and Parkinson's Disease
Sherer, T., Betarbet, R. S., & Greenamyre, J. T. (2002) · The Neuroscientist · doi:10.1177/1073858402008003004 · Cited by 247
Multiple risk factors for Parkinson's disease
Gorell, J. M., Peterson, E. L., Rybicki, B. A., & Johnson, C. C. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.09.014 · Cited by 234 · cited 1×
“…of PD (Sherer et al., 2002a); in particular, there is a strong association between PD and exposure to pesticides, including many that inhibit mitochondrial complex I (Semchuk et al., 1992; Gorell et al., 1998, 2004; Priyadarshi et al., 2000, 2001; Ascherio et al., 2006; Brown et al., 2006).”
BackgroundFerri, A., Sanes, J. R., Coleman, M. P., Cunningham, J. M., & Kato, A. C. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00206-9 · Cited by 221 · cited 4×
“Results Rotenone treatment of DRG neurons results in axonal degeneration The expression of Wld, Nmnat1, or Nmnat3 in neurons protects against axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam…”
BackgroundInfluentialAntioxidants protect PINK1 -dependent dopaminergic neurons in Drosophila
Wang, D., Li, Q., Xiong, H., Liu, J., Neckameyer, W. S., Oldham, S., Xia, K., Wang, J., Bodmer, R., & Zhang, Z. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604661103 · Cited by 203 · cited 2×
“These deficits could be rescued by expression of superoxide dismutase or treatment with the antioxidant vitamin E, suggesting that ROS was responsible for the damage (Wang et al., 2006).”
BackgroundBioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity
Nicholls, D. G., Johnson-Cadwell, L. I., Vesce, S., Jekabsons, M. B., & Yadava, N. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21290 · Cited by 173 · cited 1×
“It is possible that rotenone does cause small changes in the mitochondrial membrane potential, but the physiological significance of small changes in mitochondrial membrane potential is unclear (Nicholls, 2004; Nicholls et al., 2007).”
BackgroundDrosophila NMNAT Maintains Neural Integrity Independent of Its NAD Synthesis Activity
Zhai, R. G., Cao, Y., Hiesinger, P. R., Zhou, Y., Mehta, S. Q., Schulze, K. L., Verstreken, P., & Bellen, H. J. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040416 · Cited by 166 · cited 8×
“…axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam et al., 2003; Araki et al., 2004; Gillingwater et al., 2004; Mi et al., 2005; Sasaki et al., 2006; Zhai et al., 2006).”
BackgroundResultInfluentialJohnson-Cadwell, L. I., Jekabsons, M. B., Wang, A., Polster, B. M., & Nicholls, D. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04516.x · Cited by 164
Samsam, M., Mi, W., Wessig, C., Zielasek, J., Toyka, K. V., Coleman, M. P., & Martini, R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02833.2003 · Cited by 153 · cited 2×
“Results Rotenone treatment of DRG neurons results in axonal degeneration The expression of Wld, Nmnat1, or Nmnat3 in neurons protects against axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam…”
BackgroundRamachandiran, S., Hansen, J. M., Jones, D. P., Richardson, J., & Miller, G. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl125 · Cited by 143 · cited 1×
“…effects, such as DNA damage; oxidation of proteins, which leads to their subsequent inhibition; and oxidation of lipids, which creates toxic products, including 4-hydroxynonenal (Geller et al., 2001; Sherer et al., 2002b; Duarte et al., 2005; Keeney et al., 2006; Ramachandiran et al., 2007).”
BackgroundWlds-Mediated Protection of Dopaminergic Fibers in an Animal Model of Parkinson Disease
Sajadi, A., Schneider, B. L., & Aebischer, P. (2004) · Current Biology · doi:10.1016/j.cub.2004.01.053 · Cited by 142 · cited 2×
“Interestingly, studies with the acute 6-OHDA and MPTP rodent PD models showed that the Wld mutation provided robust protection against TH fiber loss but little or no protection of dopaminergic neuronal cell bodies (Sajadi et al., 2004; Hasbani and O’Malley, 2006).”
BackgroundConforti, L., Fang, G., Beirowski, B., Wang, M. S., Sorci, L., Asress, S., Adalbert, R., Silva, A., Bridge, K., Huang, X. P., et al. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401944 · Cited by 137 · cited 1×
“Many studies in both rodents and Drosophila have confirmed these results (Hoopfer et al., 2006; Macdonald et al., 2006; Zhai et al., 2006), whereas other investigators have suggested the Ube4b fragment may modulate the Nmnat protective effect (Wang et al., 2005; Conforti et al., 2007).”
ResultVulnerability of Central Neurons to Secondary Insults afterIn VitroMechanical Stretch
Arundine, M., Aarts, M. M., Lau, A., & Tymianski, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1362-04.2004 · Cited by 132 · cited 2×
“This would imply, as suggested by others, that ROS-stimulated processes could be a point of convergence for multiple pathways that culminate in axonal degeneration (Arundine et al., 2004; Alexandre et al., 2006; Holtz et al., 2006).”
BackgroundHoltz, W. A., Turetzky, J. M., Jong, Y.-J. I., & O’Malley, K. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04025.x · Cited by 126 · cited 2×
“This would imply, as suggested by others, that ROS-stimulated processes could be a point of convergence for multiple pathways that culminate in axonal degeneration (Arundine et al., 2004; Alexandre et al., 2006; Holtz et al., 2006).”
BackgroundOxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside
Geller, H. M., Cheng, K., Goldsmith, N. K., Romero, A. A., Zhang, A.-L., Morris, E., & Grandison, L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00395.x · Cited by 116 · cited 2×
“Excessive ROS production has multiple detrimental effects, such as DNA damage; oxidation of proteins, which leads to their subsequent inhibition; and oxidation of lipids, which creates toxic products, including 4-hydroxynonenal (Geller et al., 2001; Sherer et al., 2002b; Duarte et al., 2005; Keeney et al., 2006; Ramac…”
BackgroundMi, W. (2004) · Brain · doi:10.1093/brain/awh368 · Cited by 115 · cited 2×
“Results Rotenone treatment of DRG neurons results in axonal degeneration The expression of Wld, Nmnat1, or Nmnat3 in neurons protects against axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam…”
BackgroundInduction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons
Yang, Y., Fukui, K., Koike, T., & Zheng, X. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05914.x · Cited by 109 · cited 2×
“Mitochondrial dysfunction is often accompanied by a decrease in mitochondrial membrane potential (Nicholls, 2004), and others have suggested that dissipation of mitochondrial membrane potential precedes axonal degeneration and that the degeneration can be blocked if the mitochondrial membrane potential is preserved (I…”
BackgroundLi, B., Avshalumov, M. V., & Rice, M. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2652-05.2005 · Cited by 108 · cited 1×
“…was not directly addressed in that study; however, the results are consistent with the idea that moderate mitochondrial inhibition causes damage primarily via excess ROS production rather than through abnormalities associated with energetic deficits (i.e., decreased ATP) (Bao et al., 2005).”
ResultCompartmental neurodegeneration and synaptic plasticity in the Wlds mutant mouse
Gillingwater, T. H., & Ribchester, R. R. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00627.x · Cited by 105 · cited 1×
“…of Wlds, Nmnat1, or Nmnat3 in neurons protects against axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam et al., 2003; Araki et al., 2004; Gillingwater et al., 2004; Mi…”
BackgroundWang, M.-S., Fang, G., Culver, D. G., Davis, A. A., Rich, M., & Glass, J. (2001) · Annals of Neurology · doi:10.1002/ana.10039 · Cited by 105 · cited 3×
“Nmnat3 inhibits ROS accumulation in vincristine-treated neurons In addition to their axonal protective effects after mechanical injury or mitochondrial inhibition, Wld s and Nmnat proteins protect against vincristine-mediated axonal degeneration (Wang et al., 2001b; Araki et al., 2004).”
BackgroundIkegami, K., & Koike, T. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.057 · Cited by 105 · cited 7×
“Mitochondrial dysfunction is often accompanied by a decrease in mitochondrial membrane potential (Nicholls, 2004), and others have suggested that dissipation of mitochondrial membrane potential precedes axonal degeneration and that the degeneration can be blocked if the mitochondrial membrane potential is preserved (I…”
BackgroundMethodInfluentialJung, T. W., Lee, J. Y., Shim, W. S., Kang, E. S., Kim, S. K., Ahn, C. W., Lee, H. C., & Soo, B. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.11.020 · Cited by 103 · cited 1×
“Protection of oxidant-mediated axonal damage by Nmnat suggested that it might act via increasing neuronal expression of antioxidant proteins, including superoxide dismutase, glutathione peroxidase, and/or catalase (Thiruchelvam et al., 2005; Fernandez-Gomez et al., 2006; Jung et al., 2007).”
BackgroundCoenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
Schulz, J. B., Ross Henshaw, D., Matthews, R. T., & Flint Beal, M. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90033-0 · Cited by 103 · cited 1×
“Indeed, antioxidants provide protection for dopaminergic neurons in the MPTP, 6-OHDA, rotenone, and genetic models of PD in vivo and in vitro (Schulz et al., 1995; Matthews et al., 1999; Bahat-Stroomza et al., 2005; Testa et al., 2005; Wang et al., 2006).”
BackgroundGroninger, E., Boer, G. J. M.-D., de Graaf, S. D., Kamps, W., & de Bont, E. D. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.6.1339 · Cited by 88 · cited 2×
“Recent studies have shown that vincristine toxicity in cancer cells may be mediated by ROS and that treatment with antioxidants can inhibit vincristine-induced cell death (Groninger et al., 2002; Tsai et al., 2007).”
BackgroundRichter, F., Hamann, M., & Richter, A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21159 · Cited by 86 · cited 2×
“…mimics the degenerative progression observed in PD patients, because this model only works in rats (Hornykiewicz, 1966; Betarbet et al., 2000; Richter et al., 2007); however, our results suggest that increasing Nmnat expression in this model may rescue axonal function and thereby prevent…”
ResultMitochondriopathy in Parkinson Disease and Amyotrophic Lateral Sclerosis
Martin, L. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248541.05552.c4 · Cited by 83 · cited 3×
“The association of mitochondrial dysfunction with neurodegenerative diseases is perhaps strongest in Parkinson’s disease (PD), which can be associated with mutations in mitochondria-associated proteins (e.g., DJ-1 and PINK-1) (Martin, 2006) and ingestion of 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP), an inhib…”
BackgroundInfluentialNOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth
Ibi, M., Katsuyama, M., Fan, C., Iwata, K., Nishinaka, T., Yokoyama, T., & Yabe‐Nishimura, C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.009 · Cited by 79 · cited 2×
“…of ROS, other sources of ROS production include membrane-bound NADPH-oxidase, a source of oxidative products induced in neurons by signaling intermediates, and xanthine oxidase, which produces ROS in neurons in response to hypoxia and glucose deprivation (Ibi et al., 2006; Abramov et al., 2007).”
BackgroundDuarte, A. I., Santos, M., Oliveira, C., & Rego, A. (2005) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2005.05.002 · Cited by 79 · cited 2×
“Excessive ROS production has multiple detrimental effects, such as DNA damage; oxidation of proteins, which leads to their subsequent inhibition; and oxidation of lipids, which creates toxic products, including 4-hydroxynonenal (Geller et al., 2001; Sherer et al., 2002b; Duarte et al., 2005; Keeney et al., 2006; Ramac…”
BackgroundThe gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.
Wang, M.-S., Wu, Y., Culver, D. G., & Glass, J. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0334 · Cited by 77 · cited 3×
“Nmnat3 inhibits ROS accumulation in vincristine-treated neurons In addition to their axonal protective effects after mechanical injury or mitochondrial inhibition, Wld s and Nmnat proteins protect against vincristine-mediated axonal degeneration (Wang et al., 2001b; Araki et al., 2004).”
BackgroundWldS mice are protected against the Parkinsonian mimetic MPTP
HASBANI, D., & O’Malley, K. L. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.017 · Cited by 74
Bahat-Stromza, M., Gilgun‐Sherki, Y., Offen, D., Panet, H., Saada, A., Galron-Krool, N., Barzilai, A., Atlas, D., & Melamed, E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03889.x · Cited by 71 · cited 1×
“Indeed, antioxidants provide protection for dopaminergic neurons in the MPTP, 6-OHDA, rotenone, and genetic models of PD in vivo and in vitro (Schulz et al., 1995; Matthews et al., 1999; Bahat-Stroomza et al., 2005; Testa et al., 2005; Wang et al., 2006).”
BackgroundNeuroprotection after Transient Global Cerebral Ischemia in Wld s Mutant Mice
Gillingwater, T. H., Haley, J. E., Ribchester, R. R., & Horsburgh, K. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000095798.98378.34 · Cited by 68 · cited 1×
“…axonal degeneration resulting from damage caused by mechanical, genetic, or chemical injury (Gillingwater and Ribchester, 2001; Wang et al., 2001a,b; Ferri et al., 2003; Samsam et al., 2003; Araki et al., 2004; Gillingwater et al., 2004; Mi et al., 2005; Sasaki et al., 2006; Zhai et al., 2006).”
BackgroundWatabe, M., & Nakaki, T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.037 · Cited by 65 · cited 2×
“Several studies have indicated that increased ROS levels, and not the loss of ATP, are the proximal causes for neuronal death induced by mitochondrial inhibition (Sherer et al., 2003; Watabe and Nakaki, 2006).”
BackgroundBeyond the Bench: Tracking Clues with Environmental Health Sleuths
Tillett, T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.114-a158 · Cited by 54
Mechanism of cell death caused by complex I defects in a rat dopaminergic cell line.
Marella, M., Seo, B., Matsuno-Yagi, A., & Yagi, T. (2007) · Journal of Biological Chemistry · doi:10.1016/j.mito.2007.08.029 · Cited by 48 · cited 1×
“However, consistent with other studies with rotenone (JohnsonCadwell et al., 2007; Marella et al., 2007), we did not observe a collapse of mitochondrial membrane potential after rotenone treatment (6 h) at a time when rotenone-induced increases in ROS are already observed (Fig.”
ResultGillingwater, T. H., Wishart, T. M., Chen, P. E., Haley, J. E., Robertson, K. A., Macdonald, S. H.-F., Middleton, S., Wawrowski, K., Shipston, M. J., Melmed, S. K., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi478 · Cited by 46 · cited 1×
“It does not appear that transcriptional changes for previously identified antioxidant genes are involved (Gillingwater et al., 2006).”
BackgroundMazzio, E., & Soliman, K. (2003) · Neurochemical Research · doi:10.1023/a:1022813817743 · Cited by 45 · cited 1×
“One possibility is that Nmnat proteins increase NAD availability without increasing NADH breakdown via oxidation, thus providing more NADH for conversion to NADPH, a cofactor for many ROS-scavenging enzymes (Mazzio and Soliman, 2003).”
BackgroundFernandez-Gomez, F. J., Pastor, M., García-Martínez, E., de Mera, R. M. D., Gou-Fàbregas, M., Gomez-Lazaro, M., Calvo, S., Soler, R., Galindo, M., & Jordán, J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.005 · Cited by 43 · cited 3×
“Protection of oxidant-mediated axonal damage by Nmnat suggested that it might act via increasing neuronal expression of antioxidant proteins, including superoxide dismutase, glutathione peroxidase, and/or catalase (Thiruchelvam et al., 2005; Fernandez-Gomez et al., 2006; Jung et al., 2007).”
BackgroundTsai, S., Sun, N., Lu, H., Cheng, M., & Chao, C. C. ‐. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00513.x · Cited by 41 · cited 2×
“Recent studies have shown that vincristine toxicity in cancer cells may be mediated by ROS and that treatment with antioxidants can inhibit vincristine-induced cell death (Groninger et al., 2002; Tsai et al., 2007).”
BackgroundIntensive anti-oxidant pretreatment retards motor nerve degeneration.
Hall, E. (1987) · Brain Research · doi:10.1016/0006-8993(87)90166-1 · Cited by 40 · cited 1×
“Other insults not directly linked to mitochondrial dysfunction, including taxol, vincristine, and mechanical injury, also induce ROS and neurodegeneration (Hall, 1987; Groninger et al., 2002; Arundine et al., 2004; Alexandre et al., 2006; Holtz et al., 2006; Tsai et al., 2007).”
BackgroundNovel free radical spin traps protect against malonate and MPTP neurotoxicity.
Matthews, R. T., Klivényi, P., Mueller, G., Yang, L.-C., Wermer, M., Thomas, C. E., & Beal, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7045 · Cited by 35 · cited 1×
“Indeed, antioxidants provide protection for dopaminergic neurons in the MPTP, 6-OHDA, rotenone, and genetic models of PD in vivo and in vitro (Schulz et al., 1995; Matthews et al., 1999; Bahat-Stroomza et al., 2005; Testa et al., 2005; Wang et al., 2006).”
BackgroundAlternating metabolic pathways in NGF-deprived sympathetic neurons affect caspase-independent death
Chang, L. K., Schmidt, R., & Johnson, E. M. (2003) · Journal of Cell Biology · doi:10.1083/jcb.200302109 · Cited by 34 · cited 2×
“…luciferase-based ATP assay (Promega, Madison, WI), where ATP is expressed as a percentage of control based on arbitrary units of luminescence and then converted to micromolar ATP based on a standard curve (n 6 wells per condition; results are from two independent experiments) (Chang et al., 2003).”
Method
Cited by
Sorted by citations
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
“It has been hypothesized that increasing NAD concentration via NMNAT1 and the consequent SIRT1 activation might play a role (212, 218, 219).”
BackgroundWallerian degeneration: an emerging axon death pathway linking injury and disease
Conforti, L., Gilley, J., & Coleman, M. P. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3680 · Cited by 630
Axon degeneration in Parkinson's disease
Burke, R. E., & O’Malley, K. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 514
“…subcellular localization studies have found substantial amounts of WldS within the mitochondrial matrix where it may enhance ATP synthesis (Yahata et al., 2009), prevent free radical formation (Press and Milbrandt, 2008), and/or maintain mitochondrial membrane potential (Ikegami and Koike, 2003).”
BackgroundAxon degeneration: Molecular mechanisms of a self-destruction pathway
Wang, J. T., Medress, Z. A., & Barres, B. A. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201108111 · Cited by 464
“, 2001), fails to delay axon degeneration after axotomy (George et al., 1995; Press and Milbrandt, 2008), suggesting that Na entry is not the primary signal to trigger Ca influx, or does not lead to sufficient Ca entry to initiate Wallerian axon de generation.”
Wallerian Degeneration, WldS, and Nmnat
Coleman, M. P., & Freeman, M. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153248 · Cited by 473
“One proposal is that Nmnat activity decreases reactive oxygen species in mitochondria because it protects axons from rotenone-induced damage without restoring normal ATP levels (Press & Milbrandt 2008).”
Background
Metadata
- Authors
- Press, C., & Milbrandt, J.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Milbrandt, Jeffrey
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-05-07
- Volume
- 28
- Issue
- 19
- Pages
- 4861-4871
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2678678
- OpenAlex
- W2046359526
- Cited by
- 137
- References
- 76
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 10 · 2018: 5 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 11
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- Hope Center for Neurological Disorders
- National Institutes of Health (AG13730, NS057105)
- National Institute on Aging (AG 13730, RF1AG013730, R56AG013730, R01AG013730)
- National Institute of Neurological Disorders and Stroke (NS39358, P30NS057105, NS057105, R01NS039358)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- NMNAT1, nicotinamide mononucleotide adenylyltransferase, axonal degeneration, Wallerian degeneration, rotenone, mitochondrial dysfunction, oxidative stress, reactive oxygen species, dorsal root ganglion neurons, axonal protection, vincristine, ATP depletion
- MeSH terms
- Adenosine Triphosphate, Animals, Antioxidants, Axons, Cells, Cultured, Ganglia, Spinal, Isoenzymes, Nerve Degeneration, Neurons, Nicotinamide-Nucleotide Adenylyltransferase, Rotenone, Stress, Physiological, Vincristine, Down-Regulation, Rats, Sprague-Dawley, Gene Transfer Techniques, Oxidative Stress, Mitochondrial Diseases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review